GSK, Reckitt are the Only Suitors for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:February 4, 2018 Post category:BioPharma Companies including Sanofi, J&J, Nestle have dropped out. Source: BioSpace You Might Also Like Recipharm AB Makes Strategic Appointment In The UK & Ireland May 25, 2017 Creative Bioarray Release: New Products of FISH Have Been Released In Company January 19, 2017 Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
